David T. Curiel

Gene transfer to cervical cancer with fiber‐modified adenoviruses

D. Curiel, Hongju Wu, Minghui Wang, 2004, International journal of cancer.

Adenovirus‐mediated p16 gene transfer prevents drug‐induced cell death through G1 arrest in human glioma cells

K. Kurisu, N. Saijo, D. Curiel, 1998 .

Modulation of viability and maturation of human monocyte‐derived dendritic cells by oncolytic adenoviruses

D. Nettelbeck, D. Curiel, G. Schuler, 2008, International journal of cancer.

Adenoviral/retroviral vector chimeras: a novel strategy to achieve high‐efficiency stable transduction in vivo

D. Curiel, C. Rancourt, G. Bilbao, 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single‐chain diabody (scDb) adapter that binds to fiber knob and HMWMAA

R. Kontermann, D. Nettelbeck, A. Rivera, 2004, International journal of cancer.

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

B. Liu, A. Rivera, D. Curiel, 2003, The journal of gene medicine.

Converting nonhuman primate dendritic cells into potent antigen-specific cellular immunosuppressants by genetic modification

D. Curiel, C. Asiedu, A. Hutchings, 2002, Immunologic research.

MDA-7/IL-24 as a cancer therapeutic: from bench to bedside

P. Fisher, P. Dent, A. Yacoub, 2010, Anti-cancer drugs.

MDA‐7/IL‐24 regulates proliferation, invasion and tumor cell radiosensitivity: A new cancer therapy?

Paul Dent, P. Fisher, P. Dent, 2005, Journal of cellular biochemistry.

A Fiber-Modified Mesothelin Promoter–Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer

P. Fisher, P. Dent, D. Curiel, 2008, Clinical Cancer Research.